Published in Bioinformation on October 13, 2008
IEDB-3D: structural data within the immune epitope database. Nucleic Acids Res (2010) 0.93
The Protein Data Bank. Nucleic Acids Res (2000) 187.10
LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng (1995) 19.22
The immune epitope database and analysis resource: from vision to blueprint. PLoS Biol (2005) 7.40
SURFNET: a program for visualizing molecular surfaces, cavities, and intermolecular interactions. J Mol Graph (1995) 6.64
Improved method for predicting linear B-cell epitopes. Immunome Res (2006) 4.32
Ontology for immunogenetics: the IMGT-ONTOLOGY. Bioinformatics (1999) 3.57
Continuous and discontinuous protein antigenic determinants. Nature (1986) 3.26
AntiJen: a quantitative immunology database integrating functional, thermodynamic, kinetic, biophysical, and cellular data. Immunome Res (2005) 2.40
Bcipep: a database of B-cell epitopes. BMC Genomics (2005) 2.27
IMGT/HLA Database--a sequence database for the human major histocompatibility complex. Nucleic Acids Res (2001) 2.17
IMGT/3Dstructure-DB and IMGT/StructuralQuery, a database and a tool for immunoglobulin, T cell receptor and MHC structural data. Nucleic Acids Res (2004) 1.91
Epitome: database of structure-inferred antigenic epitopes. Nucleic Acids Res (2006) 1.70
CED: a conformational epitope database. BMC Immunol (2006) 1.39
SACS--self-maintaining database of antibody crystal structure information. Bioinformatics (2002) 1.32
MPID-T: database for sequence-structure-function information on T-cell receptor/peptide/MHC interactions. Appl Bioinformatics (2006) 1.02
Epitope recognition by diverse antibodies suggests conformational convergence in an antibody response. J Immunol (2002) 1.00
Allergy to bovine beta-lactoglobulin: specificity of human IgE to tryptic peptides. Clin Exp Allergy (1999) 1.00
Synthetic peptides versus natural antigens in immunoassays. Ann Biol Clin (Paris) (1993) 0.97
Mutational analysis of the IgE-binding epitopes of P34/Gly m Bd 30K. J Allergy Clin Immunol (2000) 0.80
Cell death: apoptosis versus necrosis (review). Int J Oncol (2002) 2.20
Aspirin is associated with lower melanoma risk among postmenopausal Caucasian women: the Women's Health Initiative. Cancer (2013) 2.14
A genome-wide association study in Han Chinese identifies new susceptibility loci for ankylosing spondylitis. Nat Genet (2011) 2.05
Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus. J Am Acad Dermatol (2008) 1.81
Redefining the p53 response element. Proc Natl Acad Sci U S A (2009) 1.36
The p53 response element and transcriptional repression. Cell Cycle (2010) 1.24
Alopecia areata: autoimmune basis of hair loss. Eur J Dermatol (2004) 1.18
Pleiotrophin enhances clonal growth and long-term expansion of human embryonic stem cells. Stem Cells (2007) 1.12
Meta-analysis of genetic polymorphisms and gastric cancer risk: variability in associations according to race. Eur J Cancer (2009) 1.10
Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts. J Am Acad Dermatol (2011) 1.04
Transcriptional profiling in alopecia areata defines immune and cell cycle control related genes within disease-specific signatures. Genomics (2010) 1.04
Modeling the bound conformation of Pemphigus vulgaris-associated peptides to MHC Class II DR and DQ alleles. Immunome Res (2006) 1.04
Cyr61/CCN1 is a tumor suppressor in human hepatocellular carcinoma and involved in DNA damage response. Int J Biochem Cell Biol (2007) 1.02
Identification of discriminators of hepatoma by gene expression profiling using a minimal dataset approach. Hepatology (2004) 1.02
Oxidative stress and autoimmune skin disease. Eur J Dermatol (2013) 0.99
Genome-wide transcriptional profiling in human squamous cell carcinoma of the skin identifies unique tumor-associated signatures. J Dermatol (2006) 0.94
Activating killer cell immunoglobulin-like receptor 2DS2 binds to HLA-A*11. Proc Natl Acad Sci U S A (2014) 0.93
Structural insights into the design of small molecule inhibitors that selectively antagonize Mcl-1. J Med Chem (2010) 0.93
Clinical applications of DNA microarray analysis. J Exp Ther Oncol (2003) 0.93
Investigation of human keratinocyte cell adhesion using atomic force microscopy. Nanomedicine (2009) 0.92
Cutaneous lupus erythematosus: understanding of clinical features, genetic basis, and pathobiology of disease guides therapeutic strategies. Autoimmunity (2006) 0.92
Structural and functional distinctiveness of HLA-A2 allelic variants. Immunol Res (2012) 0.91
Immunoinformatics: current trends and future directions. Drug Discov Today (2009) 0.89
Quantitative analysis of human keratinocyte cell elasticity using atomic force microscopy (AFM). IEEE Trans Nanobioscience (2011) 0.88
A population-based LD map of the human chromosome 6p. Immunogenetics (2005) 0.87
Cytokine networks in Pemphigus vulgaris: An integrated viewpoint. Autoimmunity (2012) 0.85
Epitope definition by proteomic similarity analysis: identification of the linear determinant of the anti-Dsg3 MAb 5H10. J Transl Med (2004) 0.85
hnRNP K suppresses apoptosis independent of p53 status by maintaining high levels of endogenous caspase inhibitors. Carcinogenesis (2013) 0.84
p53 increases MHC class I expression by upregulating the endoplasmic reticulum aminopeptidase ERAP1. Nat Commun (2013) 0.84
The role of T cells in cutaneous autoimmune disease. Autoimmunity (2005) 0.82
Compression of functional space in HLA-A sequence diversity. Hum Immunol (2003) 0.82
Monoclonal and polyclonal humoral immune response to EC HER-2/NEU peptides with low similarity to the host's proteome. Int J Cancer (2002) 0.81
Prediction of desmoglein-3 peptides reveals multiple shared T-cell epitopes in HLA DR4- and DR6-associated pemphigus vulgaris. BMC Bioinformatics (2006) 0.81
Asian population frequencies and haplotype distribution of killer cell immunoglobulin-like receptor (KIR) genes among Chinese, Malay, and Indian in Singapore. Immunogenetics (2008) 0.81
Patterns of use of sunless tanning product alternatives to indoor tanning among female college students. Arch Dermatol (2012) 0.81
Using rituximab (anti-CD20 antibody) in a patient with paraneoplastic pemphigus. J Drugs Dermatol (2003) 0.81
Proteomic definition of a desmoglein linear determinant common to Pemphigus vulgaris and Pemphigus foliaceous. J Transl Med (2006) 0.81
T cell targeted immunotherapy for autoimmune disease. Autoimmunity (2005) 0.80
Alopecia areata: genetic complexity underlies clinical heterogeneity. Eur J Dermatol (2007) 0.80
Integration of genome-wide transcriptional and genetic profiles provides insights into disease development and clinical heterogeneity in alopecia areata. Genomics (2011) 0.80
Disease relevant HLA class II alleles isolated by genotypic, haplotypic, and sequence analysis in North American Caucasians with pemphigus vulgaris. Hum Immunol (2005) 0.80
Cellular transcription modulator SMARCE1 binds to HBV core promoter containing naturally occurring deletions and represses viral replication. Biochim Biophys Acta (2007) 0.79
A cell-based system for hepatitis B virus replication: significance of clinically enhanced viral replication in relation to deletions in viral core promoter. Front Biosci (2005) 0.78
NMR probing of in silico identification of anti-HPV16 E7 mAb linear peptide epitope. Peptides (2004) 0.78
Gastric Cancer (Biomarkers) Knowledgebase (GCBKB): A Curated and Fully Integrated Knowledgebase of Putative Biomarkers Related to Gastric Cancer. Biomark Insights (2007) 0.78
Atomic force microscopy as nanorobot. Methods Mol Biol (2011) 0.78
Immunological hotspots analyzed by docking simulations: evidence for a general mechanism in pemphigus vulgaris pathology and transformation. BMC Immunol (2008) 0.77
Global transcriptional analysis of psoriatic skin and blood confirms known disease-associated pathways and highlights novel genomic "hot spots" for differentially expressed genes. Genomics (2012) 0.77
Molecular signatures of basal cell carcinoma susceptibility and pathogenesis: a genomic approach. Int J Oncol (2012) 0.77
TAP Hunter: a SVM-based system for predicting TAP ligands using local description of amino acid sequence. Immunome Res (2010) 0.77
HLA-E*0103X is associated with susceptibility to Pemphigus vulgaris. Exp Dermatol (2013) 0.77
T cell receptor Beta chain gene usage in endemic pemphigus foliaceus (fogo selvagem). J Invest Dermatol (2002) 0.77
Characterization of polyclonal antibodies raised against a linear peptide determinant of desmoglein-3. J Exp Ther Oncol (2005) 0.77
Role of MHC II affinity and molecular mimicry in defining anti-HER-2/neu MAb-3 linear peptide epitope. Peptides (2003) 0.77
Bullous pemphigoid after herpes zoster vaccine administration: association or coincidence? J Drugs Dermatol (2011) 0.76
Specific immunoglobulin isotypes correlate with disease activity, morphology, duration and HLA association in Pemphigus vulgaris. Autoimmunity (2012) 0.76
A globally available internet-based patient survey of pemphigus vulgaris: epidemiology and disease characteristics. Dermatol Clin (2011) 0.76
Gender differences in alopecia areata. J Drugs Dermatol (2014) 0.76
Preliminary data on Pemphigus vulgaris treatment by a proteomics-defined peptide: a case report. J Transl Med (2006) 0.75
Know the enemy. Nat Biotechnol (2006) 0.75
Longitudinal Tracking of Autoantibody Levels in a Pemphigus Vulgaris Patient: Support for a Role of Anti-Desmoglein 1 Autoantibodies as Predictors of Disease Progression. J Drugs Dermatol (2017) 0.75
Evaluation of a Newly Available ELISA for Envoplakin Autoantibodies for the Diagnosis of Paraneoplastic Pemphigus. J Drugs Dermatol (2015) 0.75
Gender-based variability in disease presentation in pemphigus vulgaris. J Drugs Dermatol (2014) 0.75
A case of argyria: multiple forms of silver ingestion in a patient with comorbid schizoaffective disorder. Cutis (2012) 0.75
Development of a disease registry for autoimmune bullous diseases: initial analysis of the pemphigus vulgaris subset. Acta Derm Venereol (2015) 0.75
Exploring the link between herpes viruses and pemphigus vulgaris: literature review and commentary. Eur J Dermatol (2012) 0.75
PTPN22 1858T is not a risk factor for North American pemphigus vulgaris. Exp Dermatol (2011) 0.75
Cancer prevention and therapy: strategies and problems. J Exp Ther Oncol (2003) 0.75
Rituximab Use in Pediatric Dermatology. J Drugs Dermatol (2016) 0.75
Darier's disease: a commonly misdiagnosed cutaneous disorder. J Drugs Dermatol (2008) 0.75
Lyme disease--part I: epidemiology and etiology. Cutis (2002) 0.75
Two men with toxic shock syndrome presenting with targetoid and spotty skin rashes. Acta Derm Venereol (2002) 0.75
Gene therapy in cancer: the missing point. J Exp Ther Oncol (2005) 0.75
Bullous pemphigoid associated with renal cell carcinoma and invasive squamous cell carcinoma. J Drugs Dermatol (2012) 0.75
Case and discussion of Lyme disease. J Drugs Dermatol (2003) 0.75
Reproducible Novel Transcriptional Differences Between Psoriatic Lesional and Non-Lesional Skin Show Increased Inflammation and Metabolism. J Drugs Dermatol (2015) 0.75
Nodules on the arm of a diabetic patient. Arch Dermatol (2003) 0.75
Lyme disease--part II: clinical features and treatment. Cutis (2002) 0.75